Letters
New Zealand law on new psychoactive substances
The need for sustainable regulation of tobacco products
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2033 (Published 10 March 2014) Cite this as: BMJ 2014;348:g2033
- Richard Edwards, professor1,
- Nick Wilson, associate professor1
- 1ASPIRE 2025, Department of Public Health, University of Otago, Wellington, New Zealand
- richard.edwards{at}otago.ac.nz
Newberry and colleagues draw attention to New Zealand’s new Psychoactive Substances Act,1 a novel and potentially more sustainable approach to the regulation of these substances. Key aspects of this law are the onus put on drug manufacturers to show that their products pose only a low risk of harm and the stringent restrictions on the sale and supply of these substances.
However, the authors incorrectly state that this new …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.